I'm Saurabh Sahu, founder of AFS Trading Edge in Bhopal, Madhya Pradesh, a seasoned trader and market expert committed to giving investors the tools and insights they need to succeed. Through this community, I share daily market trends, momentum strategies and trading tips to help you stay ahead and make informed decis ... Read more
Trade Ideas
475
Opinions
1k
Followers
125k
Expertise
Quantitative
Growth
Technical
Index Strategies
Swing Trading
Market Commentary
Futures & Options
Technical Analysis
Trade Facts
Total Trades
0
Missed Trades
0
Profit Trades
0
0%
Accuracy
Ask me Anything
Got a question? Ask me and I will answer it. Stay curious, stay hungry!
🚀 ABB INDIA: ORDER INFLOWS SURGE 56% YoY IN Q3 CY2026
ABB India reported strong quarterly performance, driven by robust demand in Electrification and Motion businesses.
📊 KEY HIGHLIGHTS
▪️ Revenue: ₹3,738 Cr (+19%)
▪️ New Orders: ₹4,733 Cr (+56%)
▪️ Order Backlog: ₹12,927 Cr (+36%)
▪️ Operational EBITA: ₹484 Cr (+15%)
▪️ PAT: ₹440 Cr (+10%)
▪️ Cash Balance: ₹5,299 Cr
🔍 SEGMENT HIGHLIGHTS
⚡ Electrification: Revenue +40%, Orders +117%.
⚙️ Motion: Revenue +14%, Orders +15%.
🏭 Automation: Revenue declined 16% due to execution delays.
📌 AFS INVESTOR TAKEAWAY
Strong order inflows and a growing backlog indicate healthy demand visibility, particularly in Electrification. However, margin performance and execution in Automation remain key monitorables.
Strong order book; execution will be the key to watch.
Like | Share | Follow – AFS Trading Edge
Disclaimer: For information and educational purposes only. Not investment advice.
ABB
167
63
shared an insight ⚡️ 16 hours ago
MAX HEALTHCARE: Strong Q2 Growth; 7,500+ Beds Planned
Max Healthcare Institute Limited reported healthy operating performance in Q2 FY27, supported by revenue growth, stable margins and continued expansion across its healthcare network.
📊 Q2 & H1 FY27 – Key Highlights
Q2 Revenue: ₹3,055 Cr, up 18% YoY
Q2 Operating EBITDA: ₹820 Cr
EBITDA Margin: 26.8%
Q2 PAT: ₹448 Cr
H1 Revenue: ₹5,890 Cr, up 17% YoY
H1 Operating EBITDA: ₹1,524 Cr, up 17% YoY
H1 PAT: ₹805 Cr
Operating Free Cash Flow: ₹500 Cr in Q2
🚀 Expansion & Growth Strategy
Plans to add 7,500+ beds over the next five years.
Expansion through brownfield projects, greenfield hospitals, built-to-suit models and acquisitions.
Max Lab has expanded its presence across 60+ cities.
Max@Home records 5,000+ daily billed transactions.
Max MyHealth digital platform has crossed 21 lakh patient registrations.
📌 Balance Sheet Snapshot
Gross Debt: ₹3,233 Cr
Cash & Bank Balances: ₹1,074 Cr
Shareholders' Equity: ₹12,738 Cr
Investor Insight:
Max Healthcare's performance reflects healthy revenue growth and operating profitability. Its ambitious capacity expansion and growing asset-light healthcare businesses provide additional long-term growth opportunities.
However, execution of the expansion pipeline, capital expenditure requirements and returns from new beds will remain important factors to monitor.
Disclaimer: For educational and informational purposes only. Not investment advice.
Like | Share | Follow for more market insights.
MAXHEALTH
250
77
shared an insight ⚡️ 13th Nov
🏡 GODREJ PROPERTIES EXPANDS ITS PRESENCE IN INDORE!
31-Acre Land Acquisition | ~0.7 Million Sq. Ft. Development Potential
Godrej Properties Limited has acquired approximately 31 acres of land on Indore-Ujjain Road, Indore, for a new plotted residential development.
📌 Deal Snapshot
Land Parcel: ~31 acres
Estimated Saleable Area: ~0.7 million sq. ft.
Project Type: Plotted Residential Development
Location: Indore-Ujjain Road
Portfolio: Third project in Indore
🚀 Strategic Significance
Strengthens Godrej Properties' presence in one of India's growing real estate markets.
Location benefits from connectivity to Indore Airport, Ujjain and key commercial hubs.
Upcoming metro expansion and IT-sector growth could support residential demand.
Rising preference for plotted communities offers additional growth opportunities.
📊 AFS Investor Perspective
This acquisition strengthens Godrej Properties' development pipeline in Indore and provides an opportunity to tap into the city's expanding residential market.
The long-term opportunity will depend on project execution, customer demand, pricing and monetisation.
Is Indore emerging as an important growth market for organised real estate developers?
For informational and educational purposes only. Not investment advice or a recommendation to buy or sell any securities.
GODREJPROP
Like | Share | Follow AFS Trading Edge for more corporate developments and market insights.
What are the top stock recommendations by Saurabh Sahu?
Saurabh Sahu regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include ICICI Bank Ltd. (Bullish), ABB, MAXHEALTH and GODREJPROP. Explore Saurabh Sahu's complete list of posts and trade views on their StockGro profile.
How can I follow Saurabh Sahu's latest investment insights?
You can follow Saurabh Sahu's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.
What is Saurabh Sahu's investment strategy?
Saurabh Sahu follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.
How long has Saurabh Sahu been a SEBI-registered Research Analyst (RA)?
Saurabh Sahu has been a SEBI-registered Research Analyst and have 5+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.
Where can I see Saurabh Sahu's past performance and stock picks?
You can check Saurabh Sahu's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.
How can I contact Saurabh Sahu for stock market advice?
For stock market guidance from Saurabh Sahu, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.
What is Saurabh Sahu's track record in predicting market movements?
Saurabh Sahu has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.
What is the SEBI Registration number for Saurabh Sahu?
Saurabh Sahu is a SEBI-registered Research Analyst with the SEBI Registration INH000014322. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.